Francesco Volpin
Padova, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Targeted and systemic therapies for recurrent adult ependymomas: real-world outcomes from a single institution and concise literature review.
Journal: Frontiers in oncology
Published: November 17, 2025
ZnPPIX-Loaded Nanoemulsions Reprogram Immunosuppressive Macrophages in Vitro: A Potential Strategy for Glioblastoma Microenvironment Modulation.
Journal: International journal of nanomedicine
Published: June 06, 2025
Drug-loaded nanoparticles induce immunogenic cell death and efficiently target cells from glioblastoma patients.
Journal: Nanomedicine (London, England)
Published: May 06, 2025
Bevacizumab in recurrent glioblastoma: does dose matter? Our monocentric and comparative experience.
Bevacizumab in recurrent glioblastoma: does dose matter? Our monocentric and comparative experience.
Journal: Journal of neuro-oncology
Published: January 27, 2025
A 3D morphogenetic blueprint for metastatic outgrowth in breast cancer.
Journal: Cell
Published: December 03, 2024
Indirect functional connectivity does not predict overall survival in glioblastoma.
Journal: Neurobiology of disease
Published: February 28, 2024
Patterns of gray and white matter functional networks involvement in glioblastoma patients: indirect mapping from clinical MRI scans.
Journal: Frontiers in neurology
Published: February 27, 2023
The immunosuppression pathway of tumor-associated macrophages is controlled by heme oxygenase-1 in glioblastoma patients.
Journal: International journal of cancer
Published: May 23, 2022
Newly Diagnosed Multifocal GBM: A Monocentric Experience and Literature Review.
Journal: Current oncology (Toronto, Ont.)
Published: March 28, 2022
Myeloid Diagnostic and Prognostic Markers of Immune Suppression in the Blood of Glioma Patients.
Journal: Frontiers in immunology
Published: November 05, 2021
Last Updated: 09/26/2026